20059 ⎘
Medicinal preparations characterised by special physical form; Dispersions; Emulsions; Emulsions ; Emulsion preconcentrates; Micelles Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
PHOTODYNAMIC THERAPY COMPRISING TWO LIGHT EXPOSURES AT DIFFERENT WAVELENGTHS
#2PRESSURIZED NANOEMULSION
#3LONG-ACTING TICK-REPELLING AND KILLING COMPOUNDED PLANT ESSENTIAL OIL NANO-EMULSION AND PREPARATION METHOD THEREOF
#4ANTIOXIDANT OPHTHALMIC EMULSION
#5PHARMACEUTICAL COMPOSITION COMPRISING A PICKERING'S OIL-IN-WATER EMULSION CONTAINING AN ORGANOMODIFIED PHYLLOSILICATE, PARTICULARLY FOR ITS USE AS AN ANTI-INFLAMMATORY AND ANTI-ALLERGY AGENT
#6ADMINISTRATION OF R-BETA-HYDROXYBUTYRATE SALT BLEND AND RELATED COMPOUNDS IN HUMANS
#7Advanced cannabinoid formulation for targeted management of Multiple Sclerosis
#8BIPHASIC CHRONO-ADAPTIVE NUTRACEUTICAL SYSTEM FOR ENHANCED CIRCADIAN BIOAVAILABILITY
#9PLINABULIN MICELLE COMPOSITION AND PREPARATION METHOD THEREFOR
#10TRANSDERMAL DELIVERY FORMULATIONS AND METHODS FOR THE MANUFACTURE THEREOF
#11CANNABINOID COMPOSITIONS AND METHODS OF USE THEREOF FOR IMMUNE MODULATION
#12Comprehensive Cannabinoid Compositions and Methods for the Management of Anxiety Disorders
#13Nimodipine Parenteral Administration
#14NON-FOULING OR SUPER STEALTH VESICLE
#15COMPOSITIONS AND METHODS FOR INTRANASAL DELIVERY OF CARNOSINE FOR TREATMENT OF NEURODEGENERATIVE DISEASES AND DISORDERS
#16Cannabinoid Based Nanoplatform Composition and Methods for treating knee osteoarthritis
#17Integrative Treatment for Shingles Based on Cannabinoid Compounds
#18Cannabinoid based nanoplatform composition and methods for treating breast cancer by inhibiting VEGF
#19POLYMERIC MICELLE NANOCARRIERS FOR TARGETED EPIDERMAL DELIVERY OF THE HEDGEHOG PATHWAY INHIBITOR TAK-441
#20NANOEMULSION FORMULATION WITH IMPROVED TACROLIMUS STABILITY AND SKIN PENETRATION
#21NANOEMULSION WITHOUT PROPYLENE GLYCOL
#22OIL IN WATER MICROEMULSION FORMULATION
#23NANOEMULSION-BASED NANOCREAM PRODUCT FROM GREEN INGREDIENTS EXHIBITING ENHANCED PERFORMANCE CHARACTERISTICS
#24INJECTABLE EMULSION FORMULATIONS OF CLEVIDIPINE
#25TOPICAL DELIVERY OF ANTIFUNGAL AGENTS FOR TREATING FUNGAL INFECTIONS
#26INTRANASAL DELIVERY OF CANNABINOIDS
#27PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OPHTHALMIC CONDITIONS
#28TRANSDERMAL DELIVERY FORMULATIONS
#29TRANSDERMAL DELIVERY FORMULATIONS
#30OLEOSOME COMPOSITION
#31NANO-PARTICLES OF MENAQUINONE-9 AND METHODS OF TREATMENT
#32ENCAPSULATED CANNABINOID FORMULATIONS FOR TRANSDERMAL DELIVERY
#33Methods of Delivering Alcohol-Soluble Species Including DHEA, Pregnenolone, and Chrysin for Reducing Menopausal Symptoms with Microemulsion Delivery Systems
#34METHOD OF PREPARING COENZYME Q10 OILING AGENT
#35NASAL DELIVERY OF APIGENIN AND CYCLIC PEPTIDE INHIBITORS OF MITOCHONDRIAL FISSION
#36NASAL DELIVERY OF APIGENIN AND LINEAR PEPTIDE INHIBITORS OF MITOCHONDRIAL FISSION
#37METHODS AND COMPOSITIONS FOR TREATING SEPSIS
#38COMPOSITIONS AND METHODS FOR TREATING TRANSTHYRETIN (TTR) MEDIATED AMYLOIDOSIS
#39METHODS FOR THE TREATMENT OF HYPERTENSION VIA TRANSCRANIAL-FOCUSED-ULTRASOUND
#40ELECTRONIC DEVICES AND LIQUIDS FOR AEROSOLIZING AND INHALING THEREWITH
#41IN-SITU PRODUCTION OF ANTI-INFLAMMATORY LIPIDS USING MILK FAT GLOBULES
#42TOPICAL TREATMENT OF WOUNDS WITH STATINS AND CHOLESTEROL FOR SCAR REDUCTION
#43Treatment Method and Product for Uterine Fibroids using Purified Collagenase
#44ULTRASOUND MEDIATED DELIVERY OF DRUGS
#45COMPOSITIONS AND METHODS FOR TREATING AND AMELIORATING RESPIRATORY CONDITIONS AND INFLAMMATION OF MUCOSA
#46A CYCLOSPORINE EMULSION AND PREPARATION METHOD THEREOF
#47REVERSED MICELLES FOR DELIVERY OF HYDROPHILIC DRUGS
#48COMPOSITIONS AND METHODS FOR DELIVERY OF RNA
#49PEPTIDIC WATER-SOLUBLE DELIVERY SYSTEM OF ANTICANCER DRUGS
#50EFFICIENT LIPID DELIVERY TO HUMAN TEAR FILM USING A SALT-SENSITIVE EMULSION SYSTEM
#51COMPOSITIONS AND METHODS OF USE FOR STABILIZING AND DELIVERY OF ATOMIC LAYER DEPOSITION COATING OF AGENT-CONTAINING LIPID-EMULSION FORMULATIONS
#52COMPOSITIONS AND METHODS FOR ADMINISTERING ANESTHETICS
#53METHODS AND COMPOSITIONS FOR PREVENTING SKIN TOXICITIES CAUSED BY BIOLOGICAL TARGETED CANCER DRUGS
#54CURCUMIN COMPOUND COMPOSITION
#55Non-opioid analgesic formulations of nanoemulsions
#56METHODS FOR PROCESSING, ENRICHMENT, DELIVERY, FORMULATION, AND UPTAKE FOR SUPPLEMENTS AND PHARMACEUTICALS
#57COMPOSITIONS COMPRISING LIPID DROPLETS ENCAPSULATED WITHIN POLYSACCHARIDE WALLS AND USES THEREOF
#58WATER-SOLUBLE CANNABIDIOL COMPOSITIONS AND METHOD FOR PREPARATION OF WATER-SOLUBLE CANNABIDIOL
#59O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES
#60TOPICAL OCULAR DELIVERY OF CYCLOSPORIN
#61Treatment Method and Product for Uterine Fibroids using Purified Collagenase
#62Composition
#63Natural Combination Hormone Replacement Formulations and Therapies
#64Lipid Nanoparticle Compositions and Methods For Formulating Insoluble Drugs
#65SUBSTANTIALLY SEQUENCE-UNIFORM ALIPHATIC COPOLYESTER AND METHOD OF MAKING THE SAME
#66VACCINATION WITH REPLICON PARTICLES AND OIL ADJUVANT
#67ADJUVANT COMPOSITION, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, AND METHOD FOR PREVENTING OR TREATING DISEASE CAUSED BY VIRAL INFECTION, BACTERIAL INFECTION, PROTOZOAL INFECTION OR CANCER
#68Microemulsion Pharmaceutical Composition For Treatment Of Disorders Of The Anterior Segment Of The Eye
#69METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS
#70PROCESS FOR CREATING A CANNABINOID PICO-EMULSION WITH ANTIBIOTIC PROPERTIES AND THE RESULTING PICO-EMULSION
#71NANOEMULSION COMPRISING DICLOFENAC
#72Conditioning Irradiated Tissue for Increasing Vascularity
#73METHODS OF TREATING COENZYME Q10 DEFICIENCY
#74BIOTHERAPY FOR VIRAL INFECTIONS USING BIOPOLYMER BASED MICRO/NANOGELS
#75POLYMER-LIPID NANOCOMPLEX FOR ENHANCED AQUEOUS SOLUBILISATION AND ABSORPTION OF HYDROPHOBIC ACTIVE COMPOUNDS
#76COMPOSITIONS OF FLUOROCARBON NANOEMULSION, AND METHODS OF PREPARATION AND USE THEREOF
#77COATED CONCENTRATED COMPOSITION AND USES THEREOF, USEFUL FOR CONTROLLING GASTROINTESTINAL DISEASES IN BIRDS AND IMPROVING PRODUCTIVE PARAMETERS
#78Mechano-Sensitive Microcapsules For Drug Delivery
#79NANOSTRUCTURED LIPID CARRIERS AND STABLE EMULSIONS AND USES THEREOF
#80PREPARATION METHOD AND APPLICATION FOR OIL-INWATER NANOEMULSION MATERIAL
#81NANOPARTICLE COMPOSITIONS, FORMULATIONS THEREOF, AND USES THEREFOR
#82SARS-CoV-2 VACCINE COMPOSITIONS
#83POLYOLS AND POLYOL-BASED HYDROGELS WITH ANTI-CANCER ACTIVITY
#84Means For Mitochondrial Performance Enhancement
#85OIL-IN-WATER NANOEMULSIONS AND METHODS OF PRODUCTION AND USE THEREOF
#86PROCESS OF MAKING NANOEMULSION
#87METAL-ORGANIC FRAMEWORKS AS SOLID SELF-MICROEMULSIFYING DRUG DELIVERY SYSTEMS
#88SARS-COV-2 RNA VACCINE COMPOSITIONS AND METHODS OF USE
#89TOPICAL ADMINISTRATION TO THE ORAL CAVITY
#90TOPICAL ADMINISTRATION TO THE ORAL CAVITY
#91A COMPOSITION COMPRISING LIPID NANOPARTICLES AND AN ANTIFUNGAL POLYENE
#92COMPOSITIONS OF STAUROSPORINE ANALOGS AND USES THEREOF
#93HIGHLY TRANSPARENT WATER CONTINUOUS DENSE NANOLIPID FLUID (DNLF) DISPERSIONS AND METHOD OF PREPARATION USING A TWIN SCREW EXTRUDER
#94IMMUNOMODULATORY HYDROGEL AND PREPARATION METHOD THEREOF
#95PORE IMPROVING AGENT AND SKIN IMPROVING AGENT
#96BIODEGRADABLE THERMOPLASTIC POLY(ORTHO ESTER) BASED MULTIBLOCK COPOLYMERS
#97TRANSDERMAL CARRIER
#98ANTI-INFLAMMATORY DRUG-ELUTING COMPOSITIONS AND METHODS
#99TOPICAL ADMINISTRATION TO THE ORAL CAVITY
#100FORMULATIONS WITH IMPROVED STABILITY
#101SOLANESOL VACCINE ADJUVANTS AND METHODS OF PREPARING SAME
#102EMULSION FOR NON-INVASIVE BLOOD-BRAIN BARRIER TRANSIENT OPENING AND CONTROLLED DRUG RELEASE INTO THE BRAIN
#103MOLECULAR COMPLEXING METHOD, FORMULATION AND MANUFACTURING FOR ENHANCED NUTRIENT DELIVERY
#104Acid-Base Controlled Nano-Bending Lassos to Manipulate Photo-Switching Units in [1]Rotaxanes
#105LIMIT SIZE LIPID NANOPARTICLES AND RELATED METHODS
#106ANTI-INFLAMMATORY DRUG-CANNABINOID-COMPRISING NANOEMULSIONS AND METHODS OF USING THE SAME
#107LIPID EMULSIONS AND USES THEREOF
#108DRIED NANOPARTICLE COMPOSITIONS
#109MULTICOMPONENT DEGRADABLE CATIONIC POLYMERS
#110LIPID PARTICLES, METHODS OF GENERATING SAME, AND METHODS OF USING SAME
#111A PHYTOACTIVE ENCAPSULATED FORMULATION FOR NEURODEGENERATIVE DISEASES
#112POLYMER-CARGO COMPOSITIONS AND METHODS
#113PHARMACEUTICAL DELIVERY SYSTEMS FOR HYDROPHOBIC DRUGS AND COMPOSITIONS COMPRISING SAME
#114STABLE QUERCETIN NANOSUSPENSIONS
#115SYNERGISTIC NANOMEDICINE DELIVERING TOPOISOMERASE I TOXIN (SN-38) AND INHIBITORS OF POLYNUCLEOTIDE KINASE 3'-PHOSPHATASE (PNKP) FOR ENHANCED TREATMENT OF COLORECTAL CANCER
#116WHEY PROTEIN MICELLES AGAINST MUSCLE ATROPHY AND SARCOPENIA
#117ELECTRONIC DEVICES AND LIQUIDS FOR AEROSOLIZING AND INHALING THEREWITH
#118EPA-EE LIPID NANOCOMPOSITE, FORMULATION THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#119TRANSDERMAL DELIVERY FORMULATIONS AND METHODS FOR THE MANUFACTURE THEREOF
#120NANOEMULSION ENDOWED WITH ANTISEPTIC EFFECT
#121Biotherapy for viral infections using biopolymer based micro/nanogels
#122METHOD FOR TREATING INFECTIOUS DISEASE
#123METHOD FOR TREATING AUTOIMMUNE DISEASE
#124A COMPOSITION FOR TREATING OCULAR INFECTIONS AND A METHOD OF PREPARATION THEREOF
#125WATER-SOLUBLE CANNABINOID/RETINOID BLEND FORMULATIONS AND METHODS OF THEIR MAKING
#126ERYTHROCYTE-BINDING THERAPEUTICS
#127SMALL POLYMERIC CARRIERS FOR DELIVERY OF AGENTS
#128STABLE EMULSIONS OF ANTIGENS
#129STABLE COMPOSITIONS OF MRNA-LOADED LIPID NANOPARTICLES AND PROCESSES OF MAKING
#130POLYSARCOSINE-VITAMIN E DERIVATIVES
#131RHODIOLA ROSEA NANOEMULSION AND PREPARATION METHOD THEREOF
#132NON-LIPOSOMAL SYSTEMS FOR NUCLEIC ACID DELIVERY
#133COMPOSITIONS AND METHODS FOR DELIVERY OF RNA
#134A Formulated And Synthesised Edible Birds Nest And Milk Based Nutritional Product And Methods For Preparation Thereof
#135ULTRASONICALLY-ENHANCED CONTINUOUS AND LARGE-SCALE PRODUCTION METHOD FOR NANO-FORMULATIONS
#136SELF-EMULSIFYING OIL-IN-WATER MICROEMULSION OR NANOEMULSION, AND EMULSIFYING COMPOSITION
#137A SELF-EMULSIFYING DRUG DELIVERY SYSTEM (SEDDS) OF PUNICIC ACID COMBINED WITH NEUROPROTECTIVE NATURAL PRODUCTS TO DELAY ONSET, PREVENT, OR REVERSE NEURODEGENERATIVE DISEASE
#138Pharmaceutical Preparation for Topical Delivery of Botulinum Toxin
#139DRUG LOADING MONOMOLECULAR NANO POLYMER, PRODRUG, MICELLE, DRUG DELIVERY SYSTEM, PREPARATION METHOD, AND USE
#140APPLICATION OF NOVEL CORONAVIRUS VACCINE PEPTIDE AND NANOEMULSION PREPARATION THEREOF IN PREVENTION OF NOVEL CORONAVIRUS WILD AND MUTANT STRAINS
#141CYCLOSPORINE FORMULATIONS FOR USE IN PATIENTS UNDERGOING CATARACT SURGERY
#142Solid Binding Composition for Toxin Excretion Enhancement
#143Polyols and polyol-based hydrogels with anti-cancer activity
#144NANOEMULSION COMPOSITIONS OF TAXOID DRUGS, AND METHODS FOR THE USE THEREOF TO TARGET CANCER CELLS AND CANCER STEM CELLS
#145BLOCK COPOLYMERS AND USES THEREOF
#146TARGETING NANOPARTICLES FOR THERAPY
#147Paclitaxel Prodrug, Preparation Method and Application Thereof
#148Pharmaceutical Composition Comprising Nanoparticles for the Targeted Delivery of Antigens
#149Compound Tulathromycin Nanoemulsion, and Preparation Method and Use Thereof
#150STABLE CYCLOSPORINE OPHTHALMIC FORMULATION AND MANUFACTURING PROCESS THEREOF
#151Water Dispersible Cannabinoid Compositions
#152PROCESS FOR CREATING A CANNABINOID PICO-EMULSION WITH ANTIBIOTIC PROPERTIES AND THE RESULTING PICO-EMULSION
#153A Nano Emulsified Phyto-Drug For Transdermal Treatment of Diabetes
#154DRUG FOR REDUCING BLOOD GLUCOSE AND/OR TREATING DIABETIC COMPLICATIONS
#155NANOPARTICLES FOR CANCER TREATMENT
#156Biocompatible And Allergen Free Lipid Emulsions
#157PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATORY DISEASES
#158SURVIVIN AND MAGE-A9 DUAL-TARGETED IMMUNOTHERAPY
#159ISO-OSMOTIC AND NEAR ISO-OSMOTIC OXYGEN THERAPEUTIC FORMULATIONS AND METHODS THEREOF
#160COMPOSITIONS AND METHODS FOR DEEP DERMAL DRUG DELIVERY
#161POLYMERIC MICELLE NANOPARTICLES FOR ON-DEMAND CELLULAR PACKAGING OF EXTRACELLULAR VESICLES
#162WATER SOLUBLE COMPOSITIONS AND METHODS OF MAKING THE SAME
#163AN ANTI-ANGIOGENIC AGENT AND RELATED METHODS
#164MODULATION OF SOLUBILITY, PALATABILITY, ABSORPTION, AND BIOAVAILABILITY OF MITRAGYNA SPECIOSA-DERIVED COMPOUNDS FOR ORAL AND BUCCAL DELIVERY
#165Compositions Of Dimethyl Trisulfide (DMTS) As A Cyanide Antidote
#166ANTIMICROBIAL COATING MATERIAL AND METHODS FOR PREPARATION AND APPLICATION TO SURFACES
#167TOPICAL FORMULATIONS AND USES THEREOF
#168MICROEMULSION DELIVERY SYSTEMS INCORPORATED INTO GUMMY CONFECTIONS
#169LYOPHILISED FORMULATIONS OF mRNA ADSORBED ONTO LIPID NANO-EMULSION PARTICLES
#170TRANSDERMAL DELIVERY FORMULATIONS AND METHODS FOR THE MANUFACTURE THEREOF
#171EMULSION FORMULATIONS
#172TARGETED EXTRACELLULAR VESICLES COMPRISING MEMBRANE PROTEINS WITH ENGINEERED GLYCOSYLATION SITES
#173STABLE CYCLOSPORINE OPHTHALMIC FORMULATION AND MANUFACTURING PROCESS THEREOF
#174STIMULI-INDUCED DELIVERY SYSTEMS
#175HYBRID GOLD NANOPARTICLE-LIPID NANOPARTICLES AND METHODS OF USE AND PRODUCTION THEREOF
#176Nano liquid composition containing curcumin have the ability to treating burns and increasing the effect of scar healing and method of manufacturing the same
#177NANO- OR MICRO-EMULSION COMPOSITIONS AND METHODS OF USE THEREOF
#178Transdermal Microemulsion Delivery Systems for Alcohol-Soluble Species Including Nonderivatized Hormones
#179Nanoemulsion without propylene glycol
#180PRESSURIZED NANOEMULSION
#181RNA ADSORBED ONTO LIPID NANO-EMULSION PARTICLES AND ITS FORMULATIONS
#182PARTICLE AND PHARMACEUTICAL COMPOSITION COMPRISING AN INSOLUBLE CAMPTOTHECIN COMPOUND WITH DOUBLE CORESHELL STRUCTURE AND METHOD FOR MANUFACTURING THE SAME
#183NANO-COMPLEX COMPOSITION COMPRISING DICLOFENAC
#184SOLUBILIZATE WITH AT LEAST ONE CANNABINOID
#185HIGH DENSITY PEPTIDE POLYMERS
#186PREPARATION METHOD AND APPLICATION OF A TARGETED PEPTIDE MODIFIED NANODRUG DELIVERY SYSTEM (PDC) WITH SPECIFIC BINDING TO THE NEUROTENSIN RECEPTOR (NTR)
#187OPHTHALMIC FORMULATIONS AND RELATED METHODS
#188Fermented Uni-sourced Nanoemulsion of Nigella sativa or Cannabis sativa For Use in Medical, Cosmetic, and Recreational Indications with a Method of Its Production and Use
#189MICROEMULSION FOR OPHTHALMIC DRUG DELIVERY
#190SELF-EMULSIFYING DRUG DELIVERY (SEDDS) FOR OPHTHALMIC DRUG DELIVERY
#191LIQUID DELIVERY COMPOSITION
#192TOPICAL TREATMENT OF WOUNDS WITH STATINS AND CHOLESTEROL FOR SCAR REDUCTION
#193NANO-PARTICLES OF MENAQUINONE-9 AND METHODS OF TREATMENT
#194STABLE EMULSIONS AND METHODS
#195FIDGETIN-LIKE 2 AS A TARGET TO ENHANCE WOUND HEALING
#196POLYMERIC PERFLUOROCARBON NANOEMULSIONS FOR ULTRASONIC DRUG UNCAGING
#197EFFICIENT LIPID DELIVERY TO HUMAN TEAR FILM USING A SALT-SENSITIVE EMULSION SYSTEM
#198COMPOSITIONS AND METHODS FOR THE TREATMENT AND/OR PREVENTION OF ALZHEIMER'S DISEASE
#199Neutrophil exocytosis inhibitors
#200ENZYME-RESPONSIVE POLYMER PEPTIDE AMPHIPHILES FOR TARGETED DRUG DELIVERY TO TREAT LOCAL AND SYSTEMIC INFLAMMATION
#201FORMULATIONS FOR ORAL DELIVERY OF NUCLEIC ACIDS
#202REDUCING HYDROPHOBIC DRUG ADSORPTION IN ECMO CIRCUITS
#203Contact lenses including medicaments and methods of making and using same including stabilizers of labile components such as drugs
#204NOVEL FLUOROCHEMICAL CARDIAC RESUSCITATION
#205COENZYME Q10 OILING AGENT, PREPARATION METHOD AND USE THEREOF
#206Oral care composition, and preparation method and application thereof
#207SARS-CoV-2 RNA vaccine compositions and methods of use
#208NEW OIL-IN-WATER NANOEMULSION
#209SELF-EMULSIFYING COMPOSITION OF OMEGA-3 FATTY ACID
#210STABILISED COMPOSITIONS
#211COMPOSITIONS AND METHODS OF PROMOTING ACCUMULATION OF THERAPEUTIC AND DIAGNOSTIC AGENTS IN THE HEART
#212METHODS AND COMPOSITIONS FOR TREATING SEPSIS
#213METHODS FOR REDUCING INTRAOCULAR PRESSURE
#214STABLE LIQUID PHARMACEUTICAL COMPOSITIONS HAVING HIGH DRUG LOADINGS OF MEDIUM CHAIN TRIGLYCERIDES AND METHODS RELATED THERETO
#215AN ADVENTITIAL PAINTING MODALITY OF LOCAL DRUG DELIVERY TO ABATE INTIMAL HYPERPLASIA
#216METHODS OF USE OF EMULSION FORMULATIONS OF AN NK-1 RECEPTOR ANTAGONIST
#217Topical Formulation of Disease-Modifying Antirheumatic Drug (DMARDs) for the Treatment of Rheumatoid Arthritis, Melanoma, Squamous Cell Carcinoma, Atopic Dermatitis, and Psoriasis
#218NANO- AND MICRO-FORMULATIONS
#219CANNABINOID COMPOSITION AND METHOD OF USING THE SAME
#220FULLY-DILUTABLE, SELF-MICROEMULSIFYING DELIVERY SYSTEMS (SMEDDS) FOR POORLY WATER-SOLUBLE POLAR SOLUTES
#221Solubilizate with curcumin and optionally at least one other active substance
#222Dried nanoparticle compositions
#223TOPICAL ANESTHETIC
#224CYCLIC PHOSPHONATE COMPOSITION AND PREPARATION METHOD THEREOF
#225POLYMERIC IMPLANTS
#226NANOEMULSION FORMULATION FOR TREATING DISBETES MELLITUS (DM)
#227OIL-IN-WATER EMULSIONS CONTAINING SUBMICRON HYDROPHOBIC AGENTS AND METHODS OF USE THEREOF
#228SPRAYABLE COMPOSITIONS CONTAINING OIL-IN-WATER EMULSIONS CONTAINING SUBMICRON HYDROPHOBIC AGENTS AND METHODS OF USE THEREOF
#229IMMUNE STIMULATING NANOPARTICLE COMPOSITION
#230WATER-SOLUBLE TOPICAL OPHTHALMIC PREPARATION CONTAINING LUTEIN AND PRODUCTION METHOD THEREOF
#231ORAL DELIVERY OF NANOPARTICLES FOR KIDNEY DISEASE
#232WATER-SOLUBLE CANNABIS CANNABINOID SYSTEMS FOR INFUSING PRODUCTS WITH NANOEMULSIONS HAVING NANOSCALE SIZES
#233PALM FOR THE TREATMENT OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY INCIDENTAL TO THE TREATMENT OF CANCER
#234METHODS AND FORMULATIONS FOR TREATING VASCULAR DISEASE
#235Non-liposomal systems for nucleic acid delivery
#236MPLA COMPOSITIONS AND METHODS OF USE
#237SOLID MICROCAPSULE HAVING SELF-EMULSIFYING CAPACITY
#238PHOTODYNAMIC THERAPY COMPRISING TWO LIGHT EXPOSURES AT DIFFERENT WAVELENGTHS
#239MICELLAR NANOPARTICLES AND USES THEREOF
#240HDL MIMICKING TARGETED DRUG DELIVERY SYSTEM FOR THE TREATMENT OF SOLID TUMORS
#241Polymeric Micelle Coated with Chain-Like Poorly Soluble Drug, Preparation Method and Application
#242METHOD FOR TREATING AND/OR PREVENTING EDEMATOUS FIBROSCLEROTIC PANNICULOPATHY
#243PROTONATED pH RESPONSIVE POLYMER ENCAPSULATION OF BISPECIFIC ANTIBODIES AND CYTOKINES
#244BRANCHED PEPTIDES FOR ENZYMATIC ASSEMBLY AND MITOCHONDRIA DRUG DELIVERY
#245Methods of use of emulsion formulations of an NK-1 receptor antagonist
#246Methods of use of emulsion formulations of an NK-1 receptor antagonist
#247CATIONIC AMPHIPHILIC POLYMERS FOR CODELIVERY OF HYDROPHOBIC AGENTS AND NUCLEIC ACIDS
#248Topical formulation of disease-modifying antirheumatic drug (DMARDs) for the treatment of rheumatoid arthritis, melanoma, squamous cell carcinoma, atopic dermatitis, and psoriasis
#249METHODS AND PRODUCTS FOR TREATING SUBJECTS WITH AUTISM SPECTRUM DISORDERS
#250Process of making nanoemulsion
#251VITAMIN D FORMULATIONS
#252Compositions and methods for delivery of RNA
#253COMPOSITION COMPRISING OIL DROPS
#254NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS AND THERAPIES
#255POLYMERIC MICELLE COMPLEXES OF MRNA OR ZWITTERIONIC AGENTS, AND FORMULATIONS AND USES THEREOF
#256FORMULATIONS AND METHODS FOR PULMONARY DELIVERY OF ACTIVE PHARMACEUTICAL INGREDIENTS
#257URSOLIC ACID PREPARATIONS AND USES THEREOF
#258SOLID SNEDDS BASED ON A SPECIFIC MIXTURE OF ACRYLIC POLYMERS
#259Method to improve the encapsulation efficiency and physicochemical stability of ginsenosides Rg3 and CK nano-emulsion
#260TOPICAL PHARMACEUTICAL COMPOSITIONS AND METHODS
#261DILUTABLE FORMULATIONS OF CANNABINOIDS AND PROCESSES FOR THEIR PREPARATION
#262MICELLAR NANOPARTICLES AND USES THEREOF
#263Treatment Method and Product for Uterine Fibroids using Purified Collagenase
#264METHOD FOR PREPARING STABLE LIQUID EMULSION FORMS OF PLANT EXTRACT
#265POLY-ION COMPLEX MICELLE
#266COMPOSITIONS AND METHODS FOR TREATING TRANSTHYRETIN (TTR) MEDIATED AMYLOIDOSIS
#267METHODS AND RELATED COMPOSITIONS FOR THE TREATMENT OF CANCER
#268MICROPARTICLES CONTAINING STABILIZED CBD OIL, AND METHODS FOR THE PRODUCTION THEREOF
#269Protection of Polyunsaturated Fatty Acids, Lipid-Soluble Vitamins, and Lipid-Soluble Medicaments from Oxidation
#270Long Acyl-Chain Phospholipid Oxygen Microbubbles for Treating Tumor Hypoxia
#271NANOEMULSION COMPOSITIONS FOR PREVENTING, SUPPRESSING OR ELIMINATING ALLERGIC AND INFLAMMATORY DISEASE
#272CRAC CHANNEL INHIBITOR COMPOSITIONS
#273THIOPHOSPHOPEPTIDES FOR ULTRAFAST TARGETING OF THE GOLGI APPARATUS
#274Solanesol vaccine adjuvants and methods of preparing same
#275EMBOLIZING EMULSION FOR TREATMENT OF INFLAMMATORY HYPERVASCULARIZATION ASSOCIATED WITH MUSCULOSKELETAL DISORDERS
#276COMPLEXES COMPRISING COLLAGEN PEPTIDES AND CURCUMINOIDS AND COMPOSITIONS THEREOF
#277TRIPLE STABILIZER SYSTEM
#278Targeted Nanomedicine for Treating Vascular Disorders
#279NANOEMULSION VACCINE COMPOSITIONS AND METHODS FOR SUPPRESSING REACTIVITY TO MULTIPLE FOOD ALLERGENS
#280NON-LIPOSOMAL SYSTEMS FOR NUCLEIC ACID DELIVERY
#281COMPOSITION FOR INHIBITING DIABETES MELLITUS AND METHOD OF MANUFACTURING THE SAME
#282COMPOSITION FOR INHIBITING PARKINSON'S DISEASE AND METHOD OF MANUFACTURING THE SAME
#283COMPOSITIONS AND METHODS FOR MUCOSAL DRUG DELIVERY
#284EMULSION COMPRISING SIZE-CONTROLLED DROPLETS
#285COMPOSITION, PHARMACEUTICAL COMPOSITION, USE OF A STABLE TOPICAL COMPOSITION COMPRISING A NANOEMULSION AND OF AT LEAST ONE ANTILEISHMANIAL COMPOUND, AND METHOD FOR THE TREATMENT OF CUTANEOUS LEISHMANIASIS
#286DUAL ANALGESIC/ANTI-INFLAMMATORY COMPOSITIONS COMPRISING CB2 RECEPTOR AGONISTS, COMBINATIONS, AND METHODS OF USE THEREOF
#287Ophthalmic Suspension Base having a Micro-fluidized Positively Charged Nanoparticle
#288MULTI-SUPPLEMENT DELIVERY SYSTEM
#289Small Molecule Formulation
#290TREATMENT AND PREVENTION OF INJURY DUE TO RADIATION EXPOSURE
#291Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof
#292Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols
#293COMPOSITIONS AND METHODS FOR DEEP DERMAL DRUG DELIVERY
#294PEPTIDE FORMULATIONS AND METHODS OF USE
#295PUNCTAL PLUGS CONTAINING MICELLE-ENCAPSULATED OPHTHALMIC PHARMACEUTICALS AND METHODS FOR MAKING THEREOF
#296MICROFLUIDIC PREPARATION OF FLUOROCARBON NANODROPLETS
#297Intra-Oral Nanoemulsion Including Monolayer Surfactant Bound Particles for Balancing Histamine Response
#298PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OPHTHALMIC CONDITIONS
#299Near-infrared nano-photosensitizer, and preparation method and use thereof
#300GENERATING A MICROEMULSION FORMATION WITH IMPROVED SOLUBILITY